Progressive supranuclear palsy, usually shortened to PSP, is a rare neurological condition that can affect walking, balance, eye movement, speech, swallowing, behavior, and thinking. That is a lot of territory for three words to coverand, as medical names often do, this one arrives carrying more syllables than explanations.
PSP is sometimes mistaken for Parkinson’s disease, Alzheimer’s disease, depression, an inner-ear problem, or simply “getting older.” However, it is a distinct, progressive brain disorder with recognizable patterns. Early backward falls, stiffness through the neck and trunk, slowed vertical eye movements, and limited improvement with standard Parkinson’s medication can all point clinicians toward the correct diagnosis.
There is currently no cure or proven therapy that stops PSP, but that does not mean nothing can be done. Coordinated treatment can reduce falls, make communication easier, improve swallowing safety, manage troublesome symptoms, and help families prepare for changing care needs.
What Is Progressive Supranuclear Palsy?
Progressive supranuclear palsy is an adult-onset neurodegenerative disease. “Progressive” means its symptoms worsen over time. “Supranuclear” refers to brain areas located above the nuclei that directly control certain eye movements. “Palsy” describes impaired control or weakness of muscles. Put together, the name describes one of the condition’s hallmark features: difficulty voluntarily moving the eyes, especially vertically.
PSP affects nerve cells in several areas of the brain, including parts of the brainstem and basal ganglia that help regulate posture, movement, coordination, eye control, cognition, and swallowing. It is classified as an atypical parkinsonian disorder because it can cause slowness and stiffness resembling Parkinson’s disease while following a different clinical course.
Symptoms most commonly begin after age 60, although earlier onset is possible. Estimates vary because PSP is uncommon and frequently misdiagnosed, meaning neat-looking prevalence statistics may be less neat than they appear.
What Happens in the Brain?
PSP is a tauopathy, a disease involving abnormal accumulation of a protein called tau. Healthy tau helps support the internal structure of nerve cells. In PSP, abnormal forms of tau collect within neurons and other brain cells, interfering with normal function and contributing to cell damage.
The tau involved in PSP is often described as four-repeat, or 4R, tau. Similar tau abnormalities occur in corticobasal degeneration, while other tau-related diseases have different patterns. Researchers still do not fully understand why tau begins accumulating or why particular brain regions become vulnerable.
Early Signs and Symptoms of PSP
PSP does not look identical in every person. Some people first experience falls, while others develop speech, behavior, movement, or visual symptoms. The following signs are especially important.
Unexpected Falls and Balance Problems
Repeated fallsoften backwardare among the best-known early symptoms of classic PSP. A person may walk with an unusually stiff, upright posture, pivot too quickly, sit down without controlling the descent, or lose balance without an obvious obstacle.
These incidents are not ordinary clumsiness. PSP can impair postural reflexes, visual scanning, judgment, motor planning, and the ability to correct a sudden loss of balance. Falls may consequently occur before family members realize that a neurological condition is developing.
Difficulty Moving the Eyes
PSP commonly slows or limits voluntary vertical eye movements. Looking downward may become particularly difficult, creating problems with stairs, curbs, reading, eating, or locating objects on a table. A person may move the entire head instead of shifting the eyes.
Other visual and eyelid symptoms can include blurred vision, double vision, light sensitivity, reduced blinking, involuntary eyelid closure, or difficulty opening the eyes. These problems may look like poor eyesight, but the eyes themselves are not necessarily the main culprit; the brain’s control system is misbehaving.
Movement Changes
Movement-related symptoms may include:
- Slowed movement, known as bradykinesia
- Stiffness, especially in the neck and trunk
- Difficulty starting or stopping walking
- Freezing in doorways or during turns
- An upright or backward-leaning posture
- Reduced facial expression
- Sudden, poorly controlled movements
A prominent resting tremor is less typical in PSP than in Parkinson’s disease, although tremor can occur in some PSP variants.
Speech and Swallowing Difficulties
Speech may become slow, quiet, strained, slurred, or difficult to understand. Some people develop progressive apraxia of speech, meaning the brain has increasing difficulty planning the movements required to produce words.
Swallowing problems, called dysphagia, can affect liquids, foods, saliva, and medications. Warning signs include coughing during meals, a wet-sounding voice, prolonged eating, unexplained weight loss, food remaining in the mouth, frequent throat clearing, or repeated chest infections. Silent aspirationmaterial entering the airway without an obvious coughcan also occur.
Thinking, Mood, and Behavior
PSP can affect the frontal networks responsible for planning, judgment, motivation, emotional regulation, and flexible thinking. Possible changes include apathy, impulsivity, slowed thought, irritability, reduced insight, inappropriate laughter or crying, and difficulty organizing multistep activities.
Apathy is particularly easy to misunderstand. It can look like laziness, stubbornness, or depression, but it may reflect changes in brain function rather than a deliberate withdrawal from family life.
Are There Different Types of PSP?
Yes. The classic presentation is called PSP–Richardson syndrome, which commonly involves early falls, vertical eye-movement abnormalities, axial stiffness, and cognitive or behavioral changes.
Other recognized presentations may initially resemble Parkinson’s disease, corticobasal syndrome, frontotemporal dementia, progressive gait freezing, or a primary speech and language disorder. Eye-movement problems may not appear until later in these variants, which is one reason early diagnosis can be challenging. Modern diagnostic criteria evaluate four major clinical domains: eye movement, postural stability, akinesia, and cognitive dysfunction.
PSP Versus Parkinson’s Disease
Both conditions can cause stiffness, slowed movement, reduced facial expression, and walking difficulty. Important differences often include:
| Feature | Progressive Supranuclear Palsy | Typical Parkinson’s Disease |
|---|---|---|
| Falls | May occur early, often backward | Often become prominent later |
| Posture | Frequently upright or extended | More commonly stooped forward |
| Eye movements | Vertical gaze slowing or limitation is characteristic | Major vertical gaze limitation is less typical |
| Tremor | Often absent or less prominent | Resting tremor is common, though not universal |
| Levodopa response | Usually limited or temporary | Often clearly beneficial, especially early |
No single difference proves the diagnosis. Clinicians evaluate the complete pattern and how symptoms evolve.
What Causes PSP?
The underlying cause remains unknown. Most cases are sporadic, meaning they occur without a clear family pattern. Variations near the MAPT gene, which contains instructions for producing tau, can influence risk, but having a risk-associated variation does not mean a person will inevitably develop PSP.
Rare familial cases have been reported, yet PSP is not generally inherited in a straightforward way. Researchers continue to study combinations of age-related, genetic, cellular, and environmental factors. At present, there is no proven lifestyle choice that reliably causes or prevents the condition.
How Is Progressive Supranuclear Palsy Diagnosed?
There is no single routine blood test or scan that definitively confirms PSP in a living patient. Diagnosis is primarily clinical and is usually made by a neurologist, ideally one who specializes in movement disorders or behavioral neurology.
The evaluation may include:
- A detailed history of falls, mobility changes, vision, swallowing, speech, and behavior
- A neurological examination of eye movements, posture, muscle tone, walking, balance, and reflexes
- Cognitive or neuropsychological testing
- Speech and swallowing assessments
- Brain MRI to rule out strokes, tumors, hydrocephalus, or other explanations
- Observation of the response to levodopa when Parkinson’s disease remains possible
In more advanced PSP, MRI may show shrinkage of the midbrain. On a side view, this pattern is sometimes called the “hummingbird sign.” It can support a diagnosis, but a missing hummingbird does not automatically send PSP flying off the list.
Because symptoms overlap with several neurological disorders, diagnosis may require repeated examinations over time. Input from a spouse, relative, or caregiver is often valuable, particularly when apathy, impulsivity, or reduced insight prevents the person from recognizing changes.
Treatment and Symptom Management
No available treatment has been proven to stop or reverse PSP. Management therefore focuses on preserving independence, preventing complications, and supporting quality of life. A multidisciplinary team may include a neurologist, physical therapist, occupational therapist, speech-language pathologist, dietitian, social worker, neuro-ophthalmology professional, and palliative-care specialist.
Medication
A monitored trial of levodopa may improve stiffness or slowness in some patients, particularly those with a Parkinson-like PSP presentation. Benefits are commonly modest and temporary. Botulinum toxin injections may help selected cases of eyelid spasm, excessive saliva, or painful dystonia, although injections around the neck or salivary glands require caution when swallowing is already impaired.
Other medications may be considered for depression, sleep disruption, pain, drooling, or behavioral symptoms. Treatment must be individualized because sedating or anticholinergic drugs can worsen balance, cognition, constipation, or urinary problems.
Physical and Occupational Therapy
Early physical therapy can address walking, turning, transfers, flexibility, conditioning, and balance. A cane may not provide enough multidirectional support and can become a tripping hazard. A properly fitted weighted walker or wheelchair may be safer as symptoms progress.
Occupational therapists can recommend grab bars, raised seating, shower equipment, visual contrast strips, clutter reduction, better lighting, and safer ways to dress or prepare food. Driving should be reassessed early because impaired scanning, slowed reactions, impulsivity, and limited downward gaze may make it unsafe.
Speech, Communication, and Swallowing Care
Speech-language therapy should begin before communication or swallowing problems become severe. Communication boards, alphabet cards, speech-generating devices, and simplified yes-or-no systems may help when spoken language becomes difficult.
A swallowing evaluation may lead to recommendations such as smaller bites, controlled sips, altered food textures, upright positioning, or specific swallowing maneuvers. These strategies should come from an individualized assessment rather than a one-size-fits-all internet menu. In advanced dysphagia, families may discuss feeding-tube placement while considering medical safety, comfort, personal values, and quality of life.
Planning Ahead
PSP progresses differently from person to person, but assistance generally increases over time. Early conversations about legal documents, finances, home support, preferred medical care, palliative services, and advance directives allow the person with PSP to participate while decision-making remains strong.
Advance planning is not surrender. It is closer to packing an umbrella after reading a reliable forecast: nobody is cheering for rain, but everyone is better prepared.
Complications and Outlook
Potential complications include fractures and head injuries from falls, malnutrition, dehydration, reduced mobility, pressure injuries, choking, and aspiration pneumonia. Swallowing complications are a major concern and should be addressed promptly.
PSP usually causes substantial disability over several years, but published averages cannot predict one individual’s path. The initial symptom pattern, age, general health, swallowing function, complications, and access to supportive care all influence the experience.
Research and Clinical Trials
Research is targeting tau biology, biomarkers, imaging methods, eye-movement measurements, and treatments that may slow disease progression. Scientists are also studying blood, cerebrospinal fluid, digital, and imaging markers that might make diagnosis faster and clinical trials more precise.
As of June 23, 2026, ClinicalTrials.gov listed a recruiting Phase III study evaluating NIO752, an investigational antisense treatment targeting MAPT-related tau production, in participants with PSP–Richardson syndrome. A listing does not establish that a treatment is safe or effective; it means researchers are formally testing those questions. People interested in research participation should discuss eligibility, travel, potential burdens, and known and unknown risks with their clinical team.
Experiences With PSP: A Composite Family Journey
The following fictionalized composite does not describe one real patient. It combines common experiences associated with PSP to illustrate how the condition may affect daily life.
At first, David’s family blamed the stairs. He was 67, active, and famous for insisting that instruction manuals were “merely suggestions.” When he stumbled on the final step twice in one month, everyone assumed he had moved too quickly. Then he fell backward while turning in the kitchen. There was no loose rug, slippery floor, or heroic attempt to rescue a falling casserole. He simply lost his balance.
His primary care clinician checked his blood pressure, medications, hearing, and inner-ear function. Nothing fully explained the falls. Over the following months, David became slower and stiffer. He sat upright rather than leaning forward, and his turns looked sudden and risky. His family also noticed that he no longer looked down at his plate. He lowered his entire head instead.
A neurologist initially considered Parkinson’s disease. Levodopa produced little improvement. During a later examination, David had difficulty making quick downward eye movements, and his history of early backward falls became especially important. A movement-disorder specialist eventually diagnosed probable PSP.
The diagnosis brought conflicting emotions. There was relief that the strange collection of symptoms finally had a name. There was also grief, fear, and irritation that the name sounded like a final exam question nobody had studied for.
Practical changes started small. Bright tape marked the edges of steps. Loose rugs disappeared. A grab bar appeared beside the toilet, followed by another in the shower. A physical therapist taught safer turning and transfer techniques, while an occupational therapist recommended a supportive chair that did not invite David to drop backward into it.
David disliked the walker at first. To him, it represented decline. To his wife, Maria, it represented fewer emergency-room visits. Their therapist reframed it as equipment rather than identitya tool that preserved access to the garden, family gatherings, and neighborhood walks. That argument worked better than “because I said so,” which had an impressive failure rate.
Communication gradually became harder. David’s speech was quieter and less distinct, especially when tired. Maria learned to reduce background noise, ask one question at a time, and give him longer to answer. A laminated card with common needswater, bathroom, pain, repositioning, yes, and nobecame surprisingly useful.
Meals eventually required the most attention. David coughed after drinking and sometimes packed too much food into his mouth. A speech-language pathologist arranged an instrumental swallowing study and recommended specific textures, controlled portions, slower pacing, and upright positioning. The family stopped treating meals as a race against cooling food. Safety became the main course.
Caregiving affected Maria as well. She managed appointments, equipment, insurance calls, medication lists, and the emotional weight of watching someone change. A support group gave her something clinical appointments often could not: conversations with people who understood why an ordinary shower could require planning worthy of a small military operation.
The family discussed advance directives while David could clearly express his preferences. The conversation was uncomfortable, but later decisions became less uncertain because they knew what mattered to him: comfort, time at home, familiar music, honest explanations, and continued participation in family life.
Their experience was not defined only by PSP. It also contained adapted vacations, grandchildren telling terrible jokes, quiet afternoons in the garden, and meaningful routines. The disease changed how the family did things, but careful support helped preserve why they did them.
Conclusion
Progressive supranuclear palsy is a rare, complex condition that affects far more than movement. Early falls, vertical eye-movement difficulty, axial stiffness, speech changes, swallowing problems, and alterations in behavior or executive function can help distinguish PSP from more common disorders.
Although no cure currently exists, accurate diagnosis and proactive multidisciplinary care can make everyday life safer and more manageable. Early therapy referrals, fall prevention, swallowing assessment, communication support, caregiver assistance, and advance planning are not side notes to treatmentthey are the treatment tools available today.
Medical note: This article provides general educational information and is not a substitute for diagnosis or treatment by a qualified clinician. New falls, choking, sudden neurological changes, head injuries, breathing difficulty, or signs of aspiration require prompt medical evaluation.
